Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer

Gene WritingPositive

AI Analysis

Summary

Tessera Therapeutics appoints Joseph Romanelli as President and Chief Executive Officer to lead the company's growth and advancement of its Gene Writing platform toward a clinical pipeline of genetic medicines.

Importance:3/10

Sentiment:

0.30

managementCEO appointmentgene therapyplatform innovation

Related Companies

$IPIX

Read the original article

Published by PR Newswire Biotech on July 23, 2026 5:00 PM

Read Original